Alzheimer's disease and anesthesia.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 3034231)

Published in Front Neurosci on January 31, 2011

Authors

Marie-Amélie Papon1, Robert A Whittington, Noura B El-Khoury, Emmanuel Planel

Author Affiliations

1: Département de Psychiatrie et Neurosciences, Centre Hospitalier de l'Université Laval Québec, QC, Canada.

Articles citing this

Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar. Br J Anaesth (2013) 1.26

Long-term outcomes in elderly surgical patients. Mt Sinai J Med (2012) 0.87

Isoflurane increases neuronal cell death vulnerability by downregulating miR-214. PLoS One (2013) 0.86

Anesthesia Exposure and Risk of Dementia and Alzheimer's Disease: A Prospective Study. J Am Geriatr Soc (2016) 0.86

Anesthesia and tau pathology. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.84

Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors. Sci Rep (2012) 0.82

Intranasal insulin prevents anesthesia-induced hyperphosphorylation of tau in 3xTg-AD mice. Front Aging Neurosci (2014) 0.80

Sevoflurane impairs acquisition learning and memory function in transgenic mice model of Alzheimer's disease by induction of hippocampal neuron apoptosis. Int J Clin Exp Med (2015) 0.77

Intranasal Insulin Prevents Anesthesia-Induced Spatial Learning and Memory Deficit in Mice. Sci Rep (2016) 0.77

Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro. Neurobiol Aging (2015) 0.77

On the issue of transmissibility of Alzheimer disease: a critical review. Prion (2012) 0.76

Neuroprotective Effects Against POCD by Photobiomodulation: Evidence from Assembly/Disassembly of the Cytoskeleton. J Exp Neurosci (2016) 0.76

Halothane increases neuronal cell death vulnerability by downregulating miR-214 and upregulating Bax. Int J Clin Exp Med (2013) 0.75

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps. J Vis Exp (2016) 0.75

Treatment of post-anesthesia dementia with perispinal etanercept injection and hyperbaric oxygen therapy: a case report. J Med Case Rep (2017) 0.75

Articles cited by this

An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet (2008) 14.07

Forecasting the global burden of Alzheimer's disease. Alzheimers Dement (2007) 10.01

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology (1992) 9.30

Alzheimer's disease. Lancet (2006) 9.15

Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet (1998) 7.70

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol (1999) 7.16

Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem (1986) 6.91

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science (2001) 6.00

A clinical prediction rule for delirium after elective noncardiac surgery. JAMA (1994) 5.92

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev (2000) 5.40

Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology (2008) 5.15

Plaques, tangles and dementia. A quantitative study. J Neurol Sci (1982) 4.52

Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem (2003) 3.79

Adverse cerebral effects of anaesthesia on old people. Lancet (1955) 3.53

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol (2002) 3.48

Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol (2003) 3.47

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron (1993) 3.45

Domains of tau protein and interactions with microtubules. Biochemistry (1994) 3.23

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol (2001) 3.19

Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol Cell Biol (1989) 3.09

A prospective study of delirium in hospitalized elderly. JAMA (1990) 3.02

Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci U S A (2001) 2.97

Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J Neurosci (2005) 2.94

Tau protein binds to microtubules through a flexible array of distributed weak sites. J Cell Biol (1991) 2.85

Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology (2004) 2.82

Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons. Nature (1992) 2.82

Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci (2007) 2.68

The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. J Neurosci (2007) 2.42

The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels. Anesthesiology (2006) 2.26

Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci (2007) 2.24

Alzheimer's disease and cumulative exposure to anesthesia: a case-control study. J Am Geriatr Soc (1994) 2.21

Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics. Neurobiol Aging (2007) 2.13

Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem (1993) 2.05

The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci U S A (1993) 1.99

Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem (1995) 1.86

Anesthesia with isoflurane increases amyloid pathology in mice models of Alzheimer's disease. J Alzheimers Dis (2010) 1.85

CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol Scand (2007) 1.85

Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J (1994) 1.85

Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci U S A (1997) 1.73

Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease. Curr Med Chem (2008) 1.64

Postoperative delirium in the elderly. Br J Anaesth (1994) 1.63

Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J Neurosci (2004) 1.63

Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J Biol Chem (2004) 1.58

Consensus statement: First International Workshop on Anesthetics and Alzheimer's disease. Anesth Analg (2009) 1.55

Phosphorylation of MAP2c and MAP4 by MARK kinases leads to the destabilization of microtubules in cells. Cell Motil Cytoskeleton (1999) 1.54

Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch Biochem Biophys (1998) 1.51

Early and midlife exposure to anesthesia and age of onset of Alzheimer's disease. Int J Neurosci (1994) 1.48

PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol (2001) 1.46

Exposure to anaesthetic agents, cognitive functioning and depressive symptomatology in the elderly. Br J Psychiatry (2001) 1.46

Alzheimer's disease and post-operative cognitive dysfunction. Exp Gerontol (2006) 1.41

Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia. FASEB J (2009) 1.40

Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J Biol Chem (2001) 1.40

A case-control study on Alzheimer's disease and exposure to anesthesia. Neurol Sci (2002) 1.38

Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke (2001) 1.31

The inhalation anesthetic desflurane induces caspase activation and increases amyloid beta-protein levels under hypoxic conditions. J Biol Chem (2008) 1.31

Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. J Biol Chem (2001) 1.28

Role of serine/threonine protein phosphatase in Alzheimer's disease. Neurosignals (2003) 1.28

Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells. J Biol Chem (2002) 1.23

Three- and four-repeat tau regulate the dynamic instability of two distinct microtubule subpopulations in qualitatively different manners. Implications for neurodegeneration. J Biol Chem (2005) 1.17

Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo. J Neurosci (2008) 1.15

Prediction of postoperative delirium after abdominal surgery in the elderly. J Anesth (2009) 1.14

Paired helical filament tau in Alzheimer's disease. The kinase connection. Am J Pathol (1994) 1.12

Anesthesia induces phosphorylation of tau. J Alzheimers Dis (2009) 1.11

Tau aggregates: toxic, inert, or protective species? J Alzheimers Dis (2008) 1.06

Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 1.04

A model for management of delirious postacute care patients. J Am Geriatr Soc (2005) 1.02

Anaesthetics and postoperative cognitive dysfunction: a pathological mechanism mimicking Alzheimer's disease. Anaesthesia (2010) 1.01

[Genetic and environmental factors that may influence in the senile form of Alzheimer's disease: nested case control studies]. Neurologia (2009) 0.96

Spine Surgery under general anesthesia may not increase the risk of Alzheimer's disease. Dement Geriatr Cogn Disord (2010) 0.96

Isoflurane and desflurane at clinically relevant concentrations induce amyloid beta-peptide oligomerization: an NMR study. Biochem Biophys Res Commun (2008) 0.95

Ether stress-induced Alzheimer-like tau phosphorylation in the normal mouse brain. FEBS Lett (2007) 0.93

Tau hyperphosphorylation is associated with memory impairment after exposure to 1.5% isoflurane without temperature maintenance in rats. Eur J Anaesthesiol (2010) 0.93

Inhaled anesthetic modulation of amyloid beta(1-40) assembly and growth. Curr Alzheimer Res (2007) 0.92

Alzheimer's disease: role of aging in pathogenesis. Ann N Y Acad Sci (2002) 0.90

Neurocognitive impairment and driving performance after coronary artery bypass surgery. Eur J Cardiothorac Surg (2003) 0.89

Anesthetics and tau protein: animal model studies. J Alzheimers Dis (2010) 0.88

Abeta peptide interactions with isoflurane, propofol, thiopental and combined thiopental with halothane: a NMR study. Biochim Biophys Acta (2008) 0.88

Effect of general anesthetics on amyloid precursor protein and mRNA levels in the rat brain. Neurochem Res (2005) 0.88

Alzheimer's disease and anaesthesia. Anaesthesia (2000) 0.87

Tau in neurodegenerative diseases: tau phosphorylation and assembly. Neurotox Res (2004) 0.86

Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry (2001) 0.85

Cognitive dysfunction after surgery and anaesthesia: what can we tell the grandparents? Age Ageing (2009) 0.84

Hypothermia and Alzheimer's disease neuropathogenic pathways. Curr Alzheimer Res (2010) 0.82

Anaesthesia generates neuronal insulin resistance by inducing hypothermia. BMC Neurosci (2008) 0.82

Alzheimer's disease amyloid beta-clipping enzyme (APP secretase): identification, purification, and characterization of the enzyme. Biochem Biophys Res Commun (1991) 0.80

Anesthetic considerations in patients with Alzheimer's disease. J Clin Anesth (2003) 0.78

Anesthetic considerations for patients with Alzheimer's disease. Tex Med (1985) 0.78

[Cognitive dysfunction after cardiac surgery]. Masui (2009) 0.77

Rate of recovery of temperature-regulating responses after ether anesthesia. Am J Physiol (1948) 0.76

Articles by these authors

Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. JAMA (2005) 4.54

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A (2005) 2.95

Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation. Proc Natl Acad Sci U S A (2008) 2.09

Postoperative cognitive decline: where art tau? Anesthesiology (2012) 1.98

Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet (2010) 1.83

Dissociable influences of opiates and expectations on pain. J Neurosci (2012) 1.81

Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc Natl Acad Sci U S A (2002) 1.66

Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron (2008) 1.59

Endogenous gamma-aminobutyric acid modulates tonic guinea pig airway tone and propofol-induced airway smooth muscle relaxation. Anesthesiology (2009) 1.55

Consensus statement: First International Workshop on Anesthetics and Alzheimer's disease. Anesth Analg (2009) 1.55

Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology (2007) 1.53

Sudden amnesia resulting in pain relief: the relationship between memory and pain. Pain (2007) 1.52

A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease. J Pharmacol Exp Ther (2008) 1.41

Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia. FASEB J (2009) 1.40

Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. J Neurosci (2008) 1.28

Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. Am J Pathol (2009) 1.27

Propofol directly increases tau phosphorylation. PLoS One (2011) 1.25

Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells. J Biol Chem (2002) 1.23

Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo. J Neurosci (2008) 1.15

MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum Mol Genet (2011) 1.11

A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Neurobiol Dis (2008) 1.09

Comparison of the effects of sevoflurane and isoflurane anesthesia on the maternal-fetal unit in sheep. J Anesth (2009) 1.06

Tau aggregates: toxic, inert, or protective species? J Alzheimers Dis (2008) 1.06

U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy. J Neurochem (2004) 1.03

In vivo turnover of tau and APP metabolites in the brains of wild-type and Tg2576 mice: greater stability of sAPP in the beta-amyloid depositing mice. PLoS One (2009) 1.02

Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behav Brain Res (2012) 1.00

Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies. Methods Mol Biol (2012) 0.92

Untangling memory deficits. Nat Med (2005) 0.89

c-jun N-terminal kinase hyperphosphorylates R406W tau at the PHF-1 site during mitosis. FASEB J (2006) 0.87

Gene network and pathway analysis of mice with conditional ablation of Dicer in post-mitotic neurons. PLoS One (2012) 0.86

Deregulation of protein phosphatase 2A and hyperphosphorylation of τ protein following onset of diabetes in NOD mice. Diabetes (2012) 0.85

Anesthesia and tau pathology. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.84

Specifying the non-specific factors underlying opioid analgesia: expectancy, attention, and affect. Psychopharmacology (Berl) (2013) 0.82

Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors. Sci Rep (2012) 0.82

Dimethyl sulfoxide induces both direct and indirect tau hyperphosphorylation. PLoS One (2012) 0.80

Anesthesia-induced hypothermia mediates decreased ARC gene and protein expression through ERK/MAPK inactivation. Sci Rep (2013) 0.78

Highly sensitive chromatographic assay for dopamine determination during in vivo cerebral microdialysis in the rat. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.78

Anesthesia, surgery and neurodegeneration. Preface. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.75

Physical Activity and Cognitive Development: A Meta-Analysis. J Neurosurg Anesthesiol (2016) 0.75